Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant

Status:
Completed

Trial end date:
2013-10-01

Target enrollment:

Participant gender:

This is an study evaluating the safety, tolerability, and PK of EN3342 in implantation durations of 6 months.

Phase 1

Endo Pharmaceuticals

Risperidone